GT Biopharma, Inc. Announces it has Completed Enrollment in Proof-of-concept Clinical Trial for its Novel Treatment for Motion Sickness
GT Biopharma, Inc. announced today that the Proof-of-Concept clinical trial with GTP-011, a novel treatment for the symptoms of motion sickness, that was initiated in late February 2018 is fully enrolled. The study is a single-blind, placebo-controlled, cross-over study. The primary objective of the study will be to demonstrate the anti-motion sickness efficacy of transdermal GTP-011.
Read The Full Article Here
One Marijuana Stock that’s Being Called The Priceline Of Pot!
We’ve been covering One Public Marijuana Company for a few weeks now and as the broader markets continue to get beaten up, this marijuana stock is up nearly 30% since March 29 [this could be just the start]
Read The Full Article Here
How U.S. Legislation is Affecting the Marijuana Stock Market in Canada
The addition of legal cannabis into the global atmosphere has helped to boost existing markets throughout places like Canada and the U.S. With the market showing itself to be extremely lucrative over the past several years, sales in the North American market have jumped by as much as 33% to almost $10 billion as of the end of 2017. Because of new tax cuts throughout America, the market has been able to flourish through the growing trend of marijuana legalization throughout the country.
Read The Full Article Here
Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
Disclaimer: An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $1,800,000.00 by a GT Biopharma Inc. for a period beginning August 1, 2017 and ending April. 30, 2018 to publicly disseminate information about (GTBP). We own zero shares. An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by a GT Biopharma Inc. for a period beginning May 1, 2018 and ending May. 31, 2018 to publicly disseminate information about (GTBP). We own zero shares. Full Disclaimer Here
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
